Literature DB >> 11944983

Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family.

Agnieszka Pietas1, Karsten Schlüns, Ingo Marenholz, Beat W Schäfer, Claus W Heizmann, Iver Petersen.   

Abstract

S100 proteins form a growing subfamily of proteins related by Ca2+-binding motifs to the Efhand Ca2+-binding protein superfamily. By analyzing a human lung cancer cell line subtraction cDNA library, we have identified and characterized a new member of the human S100 family that we named S100A14 (GenBank acc. no. NM_020672). It encodes a mRNA present in several normal human tissues of epithelial origin, with the highest level of expression in colon. The full-length cDNA is 1067 nt in length, with a coding region predicting a protein of 104 amino acids that is 68% homologous to the S100A13 protein. The deduced amino acid sequence of the human S100A14 and its mouse homolog (identified as GenBank entry) contains two EF-hand Ca2+-binding domains, a myristoylation motif, a glycosylation site, and several potential protein kinase phosphorylation sites. We have mapped this gene to human chromosome 1q21, within a region where at least 15 other S100 genes are tightly clustered. A 3.2-kb genomic fragment containing the entire S100A14 was cloned and sequenced. The gene is split into four exons and three introns spanning a total of 2165 bp of genomic sequence. We examined the intracellular distribution of the epitope-tagged S100A14 protein in two human lung carcinoma cell lines and one immortalized monkey cell line. Pronounced staining was observed in the cytoplasm, suggesting an association with the plasma membrane and in the perinuclear area. We also provide evidence for heterogenic expression of S100A14 in tumors, demonstrating its overexpression in ovary, breast, and uterus tumors and underexpression in kidney, rectum, and colon tumors, a pattern suggesting distinct regulation with potentially important functions in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944983     DOI: 10.1006/geno.2002.6744

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

1.  Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.

Authors:  Li-Yu Cao; Yu Yin; Hao Li; Yan Jiang; Hong-Fu Zhang
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

2.  Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.

Authors:  Qingying Zhang; Min Zhu; Wenxiang Cheng; Rui Xing; Wenmei Li; Min Zhao; Liyan Xu; Enmin Li; Guangbin Luo; Youyong Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-30       Impact factor: 4.553

3.  S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.

Authors:  Xiangyu Wang; Jing Yang; Jingfeng Qian; Zhihua Liu; Hongyan Chen; Zhumei Cui
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  Overexpression of S100A14 in human serous ovarian carcinoma.

Authors:  Jingfeng Qian; Fang Ding; Aiping Luo; Zhihua Liu; Zhumei Cui
Journal:  Oncol Lett       Date:  2015-12-01       Impact factor: 2.967

5.  Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.

Authors:  Hongyan Chen; Yi Yuan; Chunpeng Zhang; Aiping Luo; Fang Ding; Jianlin Ma; Shouhui Yang; Yanyan Tian; Tong Tong; Qimin Zhan; Zhihua Liu
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

6.  S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway.

Authors:  Shaoqin Jiang; Yaru Zhu; Zhenlin Chen; Zhangcheng Huang; Bingqiao Liu; Yue Xu; Zhihao Li; Zequn Lin; Mengqiang Li
Journal:  Hum Cell       Date:  2021-04-23       Impact factor: 4.174

7.  S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.

Authors:  Chengshan Xu; Hongyan Chen; Xiang Wang; Jidong Gao; Yiqun Che; Yi Li; Fang Ding; Aiping Luo; Shuguang Zhang; Zhihua Liu
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

8.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

9.  Differential expression of S100 gene family in human esophageal squamous cell carcinoma.

Authors:  Junfang Ji; Liqun Zhao; Xiuqin Wang; Chuannong Zhou; Fang Ding; Lei Su; Chunlin Zhang; Xuezheng Mao; Min Wu; Zhihua Liu
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-04       Impact factor: 4.553

10.  Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.

Authors:  Narasimharao V Marella; Kishore S Malyavantham; Jianmin Wang; Sei-ichi Matsui; Ping Liang; Ronald Berezney
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.